Status:
COMPLETED
Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Arthritis, Rheumatoid
Medication Adherence
Eligibility:
All Genders
21+ years
Brief Summary
This study aims to provide preliminary evidence of the validity of a sensor-based assessment of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA Enbrel patien...
Detailed Description
Patients with rheumatoid arthritis (RA) often endure a remitting and flaring disease-course characterized by considerable pain, stiffness, and fatigue. The social and emotional well-being of RA patien...
Eligibility Criteria
Inclusion
- Enbrel users between week -2 and week 5 of therapy, inclusive.
- Current active prescription for Enbrel with intent to use.
- 21 years or older.
- English speaking
- Have an understanding, ability, and willingness to fully comply with study procedures and restrictions.
Exclusion
- Allergic to latex or dry natural rubber
- Using a pacemaker, implantable cardiac defibrillator, neurostimulator, hearing aids, cochlear implants or other electronic medical equipment.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT02296632
Start Date
November 1 2014
End Date
August 1 2015
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048